Charles River Laboratories International (CRL) Inventory (2009 - 2026)

Charles River Laboratories International has reported Inventory for 18 years, with the latest figure at $346.3 million in Q2 2026.

• On a quarterly basis, Inventory rose 23.86% year-over-year to $346.3 million in Q2 2026; TTM through Jun 2026 was $346.3 million, a 23.86% increase from a year earlier, with the FY2025 full-year figure at $299.1 million, up 7.38% from the prior year.
• Inventory was $346.3 million for Q2 2026 at Charles River Laboratories International, down from $359.7 million in the prior quarter.
• The five-year high for Inventory was $380.3 million in Q4 2023, with the low at $221.2 million in Q1 2022.
• Average Inventory over 5 years is $301.0 million, with a median of $291.6 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Inventory jumped 48.65% in 2023, then decreased 26.75% in 2024.
• Over 5 years, Inventory stood at $255.8 million in 2022, then jumped by 48.65% to $380.3 million in 2023, then decreased by 26.75% to $278.5 million in 2024, then rose by 7.38% to $299.1 million in 2025, then climbed by 15.77% to $346.3 million in 2026.
• The last three Inventory figures came in at $346.3 million (Q2 2026), $359.7 million (Q1 2026), and $299.1 million (Q4 2025), per Business Quant data.